Cybrdi, Inc. Stock

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-50.91%

17-10-30	Xi’an Alena Biotechnology Co., Ltd completed the acquisition of 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc..	CI
17-07-18	Xi’an Alena Biotechnology Co., Ltd entered into a share transfer agreement to acquire 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc. for CNY 25.6 million.	CI

Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Companyâ€™s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
CYDI Stock

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	2.52M 2.18M 2.06M 1.87M 3.5M 241M 3.52M 24.46M 9.41M 123M 9.48M 9.27M 388M	P/E 2012	-1.82x	P/E 2013	-2.85x
Enterprise Value	6.51M 5.61M 5.31M 4.82M 9.04M 622M 9.08M 63.12M 24.27M 317M 24.47M 23.93M 1B	EV / Sales 2012	3.25x	EV / Sales 2013	9.67x
Free-Float	29.19%	Yield 2012 *	-	Yield 2013	-

Manager	Title	Age	Since
Yan Biao Bai CEO	Chief Executive Officer	63	2002-12-31
Yong Hong Ren COO	Chief Operating Officer	-	2011-08-18

Director	Title	Age	Since
Yan Biao Bai CHM	Chairman	63	2002-12-31
Yong Hong Ren BRD	Director/Board Member	-	2011-08-18

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYBRDI, INC.	-.--%	-.--%	-	-	325K
LONZA GROUP AG	-0.71%	-6.35%	-2.99%	+9.37%	45.48B
REVOLUTION MEDICINES, INC.	+0.21%	-2.98%	+337.74%	+520.30%	43.68B
IQVIA HOLDINGS INC.	+1.74%	-2.24%	+39.82%	+20.85%	43.09B
BEONE MEDICINES AG	+1.38%	-3.28%	+6.84%	+73.19%	39.4B
CELLTRION, INC.	-1.44%	-5.26%	+8.97%	+39.76%	31.91B
ASCENDIS PHARMA A/S	+0.87%	-2.60%	-	-	17.31B
MEDPACE HOLDINGS, INC.	+0.75%	-0.64%	+19.75%	+108.58%	16.4B
EUROFINS SCIENTIFIC SE	-0.31%	-2.78%	+10.78%	+30.20%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.93%	-3.55%	+82.00%	+36.66%	13.28B
Average	+0.44%	-2.88%	+62.86%	+104.87%	26.48B
Weighted average by Cap.	+0.41%	-3.50%	+74.57%	+124.86%

	2012	2013
Net sales	783K 675K 639K 579K 1.09M 74.82M 1.09M 7.59M 2.92M 38.07M 2.94M 2.88M 120M	574K 495K 468K 425K 797K 54.86M 801K 5.56M 2.14M 27.91M 2.16M 2.11M 88.2M
Net income	-530K -456K -432K -392K -735K -50.61M -739K -5.13M -1.97M -25.75M -1.99M -1.95M -81.37M	-548K -472K -447K -405K -761K -52.39M -765K -5.31M -2.04M -26.65M -2.06M -2.01M -84.22M
Net Debt	1.58M 1.36M 1.29M 1.17M 2.2M 151M 2.21M 15.34M 5.9M 76.95M 5.95M 5.82M 243M	3.99M 3.44M 3.26M 2.95M 5.54M 381M 5.56M 38.66M 14.87M 194M 14.98M 14.66M 613M

Cybrdi, Inc. Stock

Stocks

CYDI

US23254K1007

Biotechnology & Medical Research

Valuation : Cybrdi, Inc.

Latest news : Cybrdi, Inc.

Managers and Directors : Cybrdi, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile